However, in a NOXA-null melanoma line Hs852T, the combination treatment was very effective in reducing the cell viability (Fig. 6a, c, upper panel), increasing the cleaved product of PARP (Fig. 6b), and disrupting the primary spheres (Fig. 6c, lower panel). Here, PMAIP1 is linked to melanoma.